Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Over 200 delegates travelled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH 2018) in Oxford from 23-28 Sept. The conference, at Keble College, brought together experts in pharmacy, public health, chemistry, law, sociology, governance and ethics, from medicines regulatory authorities, academia, pharmaceutical industry, NGOs, and international organisations.

MQPH discussion panel, with Celine Caillet, Serena Vickers, Muhammad Zaman, Richard Jahnke

The many conference partners included the US Pharmacopeia (USP), WHO, Wellcome and the Concept Foundation. The latest evidence on the prevention, detection and response to substandard, falsified and unregulated medicines was discussed along with inspiring collaborations and strategies to tackle this global challenge.

Opening speakers Dr Suzanne Hill, Director of the Essential Medicines and Health Products Department of the World Health Organization (WHO), Prof Louise Richardson, Vice-Chancellor of the University of Oxford, Ms Agnes Sitta Kijo, Acting Director General of the Tanzanian Food and Drugs Authority (TFDA), and Prof Sir Nicholas White, Chairman of the MORU Tropical Health Network, called for collaborative efforts beyond geographic borders and sectoral divisions to more urgently intervene to address the serious public health problem of substandard and falsified medical products.

A brief Oxford Statement, under the auspices of the conference and the Let's Demand Medicines We Can Trust campaign, was released 14 Nov 2018. Prof Paul Newton, LOMWRU Director and Head of the IDDO Medicine Quality Group explained: “The conference consensus statement outlines the key opportunities and priority ‘next steps’ to tackle poor quality medicines. We hope to organize many more opportunities to collaborate and make a real difference to the lives of those affected by this unacceptable global health challenge.”

The full story is available on the Oxford Tropical Medicine website

Similar stories

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

COPCOV investigators meet, and prepare to submit for publication

On 15-16 Dec, COPCOV investigators from around the world met in Bangkok to review study results and plan next steps. Led by co-PIs Prof Sir Nick White and Dr Will Schilling, and funded by the Wellcome Trust, the MORU-led COPCOV ( Chloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting) is the world’s largest multinational trial of COVID-19 prevention.

Expert Comment: Biotechnology allows us to make unprecedented interventions for conservation

In the wake of high-profile reports on the devastating toll human activity has had on global biodiversity, nations are expected to adopt the Convention on Biodiversity post-2020 framework that outlines measures to ensure humans live in harmony with nature.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Are we getting tafenoquine dosing right?

Researchers analysing clinical trial data for the new antimalarial drug tafenoquine find that higher doses are needed to cure reliably vivax malaria infection.

New SMRU building opened in Thailand to provide health care to marginalized populations

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.